Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2006
06/20/2006US7063964 Nucleic acids encoding IL-12 antibody
06/20/2006US7063962 DNA sequences for regulating transcription
06/20/2006US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells.
06/20/2006US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity
06/20/2006US7063953 Human voltage gated sodium channel β1A subunit and methods of use
06/20/2006US7063950 Nucleic acids encoding human calcium channel and methods of use thereof
06/20/2006US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
06/20/2006US7063851 Herpes viruses for immune modulation
06/20/2006US7063845 Human anti-CD40 antibodies
06/20/2006US7063841 Mammalian cell surface antigens; related reagents
06/20/2006US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases
06/20/2006CA2049472C Monoclonal antibodies to leptosphaeria
06/15/2006WO2006063292A1 Recombinant method for making multimeric proteins
06/15/2006WO2006063182A2 Orthopic reconstituted human breast tumor model in mouse
06/15/2006WO2006063121A2 Method and system for gps augmentation of mail carrier efficiency
06/15/2006WO2006062989A1 Three-dimensional cell culsture system
06/15/2006WO2006062698A2 Genes that determine plant color and uses thereof
06/15/2006WO2006062664A2 Method to administer stem cells in combination with one or more acoustically active materials and ultrasound energy
06/15/2006WO2006062259A1 Method for production of plant cell having chromosome loss
06/15/2006WO2006062134A1 Ip3 receptor-deficient mouse
06/15/2006WO2006062094A1 Novel cancer antigen peptide and the use thereof
06/15/2006WO2006061717A2 Materials and methods related to dickkopfs (dkk) and neurogenesis
06/15/2006WO2006061626A2 Complexes and methods
06/15/2006WO2006061416A1 Human stem cell lines derived from es cells and uses for production of vaccines and recombinant proteins
06/15/2006WO2006061242A2 Use of pta peptides for stratification of individuals having cancer
06/15/2006WO2006060898A1 Method for treating inflammatory disorders
06/15/2006WO2006044790A3 Compositions and methods for prolonging survival of platelets
06/15/2006WO2006043972A8 Chimeric protein
06/15/2006WO2006037033A3 A microfluidic device for enabling the controlled growth of cells
06/15/2006WO2006032278A9 Subtilases
06/15/2006WO2006026537A3 Site-specific recombination systems for use in eukaryotic cells
06/15/2006WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof
06/15/2006WO2005123903A3 Culture aid for cells and tissues
06/15/2006WO2005113743A3 Device for carrying out a liquid/air culture of epithelium
06/15/2006WO2005107651A3 Cell permeable structural implant
06/15/2006WO2005100590A3 Cell display libraries
06/15/2006WO2005100401A3 Monoclonal antibodies with specificity for fetal erythroid cells
06/15/2006WO2005003320A3 Neuronal differentiation of stem cells
06/15/2006WO2004094596A8 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
06/15/2006WO2003044164A3 Cell substrates and methods of use thereof
06/15/2006US20060130188 Inbred corn line PHCND
06/15/2006US20060130184 Seed-preferred regulatory elements
06/15/2006US20060130183 Modification of plant lignin content
06/15/2006US20060130181 Plant cells and plants which synthesize a starch with an increased final viscosity
06/15/2006US20060130179 Lambda integrase mediated recombination in plants
06/15/2006US20060130177 Such as blast fungus and/or leaf-blight bacteria by transforming plants with DNA encoding protein that induces hypersensitive reaction-like lesion mimic; progeny, seeds, plants
06/15/2006US20060130176 MicroRNAs
06/15/2006US20060130175 Polynucleotide of given sequence; expression cassettes linked to gene encoding toxins or use as markers; control moths
06/15/2006US20060130174 Transposon and transposase genes of rice, transposase, transformant and method of use
06/15/2006US20060130171 Organogenic transformation and regeneration
06/15/2006US20060130170 Avian transgenesis using a chicken ovalbumin gene region
06/15/2006US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
06/15/2006US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells
06/15/2006US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin
06/15/2006US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin
06/15/2006US20060130165 F066 transgenic mice that express pathogenic mutants of the sca2 gene
06/15/2006US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP)
06/15/2006US20060129174 Microstructures for delivering a composition cutaneously to skin
06/15/2006US20060129071 Method and apparatus for mechanical stimulation of tissue in vitro
06/15/2006US20060128650 Allele-specific RNA interference
06/15/2006US20060128018 Directed genetic modifications of human stem cells
06/15/2006US20060128016 Fibrin-containing composition
06/15/2006US20060128015 Small hepatocyte-rich colonies, process for preparing the colonies, process for maturating the colonies into liver tissue and method of estimating effects of drug by using matured small hepatocyte-rich colonies
06/15/2006US20060128014 Compositions and methods for culturing stem cells
06/15/2006US20060128013 Directed differentiation of embryonic cells
06/15/2006US20060128012 Substrate recognition by differentiable human mesenchymal stem cells
06/15/2006US20060128011 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells
06/15/2006US20060128010 Applying a compressive force to a stack of sheets of living tissue thereby inducing adjacent layers to fuse or adhere to each other; two different types of sheets and/or consist of between two and twelve sheets of living tissue; improved fusion between layers of tissue; less less likely to separate
06/15/2006US20060127994 Aldehyde dehydrogenase gene
06/15/2006US20060127988 Using site directed mutagenesis of regulatory/enhancer sequences to improve efficiency of vector transformation and expression
06/15/2006US20060127983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2006US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof
06/15/2006US20060127978 Nucleic acid recombination method, host cell and expression vector
06/15/2006US20060127977 Family of mammalian G protein-coupled heteromeric receptors that specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweeteners and are expressed by recombinant host cells
06/15/2006US20060127975 Method for culturing cells in order to produce substances
06/15/2006US20060127954 N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
06/15/2006US20060127937 Novel Survivin interacting protein TPR1
06/15/2006US20060127927 Mammalian IAP gene family, primers, probes, and detection methods
06/15/2006US20060127921 PECAM-1-related molecules compositions kit of parts and associated methods of use
06/15/2006US20060127914 Nicotinic acetylcholine receptor
06/15/2006US20060127902 Brain endothelial cell expression patterns
06/15/2006US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines
06/15/2006US20060127894 Protein associated with cell growth, differentiation, and death
06/15/2006US20060127893 Modification of human variable domains
06/15/2006US20060127887 Isolation and purification method of biomolecules using hydrogel
06/15/2006US20060127883 medical equipment for sorting of living cells in immunology, medical therapeutics; separating preferential cells that displays a marker molecule , detect in sample, expose sample to acoustic vibration, electromagnetic energy; cellular array; screening the cells; analytic apparatus
06/15/2006US20060127876 Tissue engineering; prevent immune reaction when implanted
06/15/2006US20060127875 Device for separation of platelets from whole blood
06/15/2006US20060127874 Separating plasma from whole blood obtained from human or animal, reducing leukocytes in plasma by filtering through leukocyte reducing filter, filtering leukocyte-reduced plasma through first and second virus removal membranes in series having decreasing pore diameters, where plasma has not been frozen
06/15/2006US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
06/15/2006US20060127495 Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue
06/15/2006US20060127419 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
06/15/2006US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy
06/15/2006US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone
06/15/2006US20060127399 Compositions and methods for inducing chimerism in a subject
06/15/2006US20060127398 Monoclonal antibody capable of binding integrin alpha 10 beta 1
06/15/2006US20060127394 Cloning of honey bee allergen
06/15/2006US20060127393 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases
06/15/2006US20060127388 Variants of glycogen synthase kinase 3 and uses thereof
06/15/2006US20060127382 Particle/cell separation device and compositions